Wai Chun Bio-Technology Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was HKD 287.873 million compared to HKD 247.104 million a year ago. Net loss was HKD 4.474 million compared to net income of HKD 77,000 a year ago. Basic loss per share from continuing operations was HKD 0.00268 compared to basic earnings per share from continuing operations of HKD 0.00005 a year ago. Diluted loss per share from continuing operations was HKD 0.002684 compared to diluted earnings per share from continuing operations of HKD 0.000046 a year ago.